Prelude Therapeutics Balance Sheet (2023-2026) | PRLD

Balance Sheet Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 29.34M28.75M31.87M15.18M16.52M44.31M77.30M50.77M35.26M84.80M
Short-term Investments (Quarter) 207.64M177.22M152.02M142.49M121.14M58.80M47.46M7.42M67.96M59.80M
Cash & Current Investments (Quarter) 236.98M205.97M183.89M157.67M137.66M103.12M124.76M58.19M103.21M144.60M
Prepaid Assets (Quarter) 2.65M3.44M2.87M2.76M2.28M3.33M3.66M3.37M2.48M3.04M
Current Assets (Quarter) 235.59M205.37M182.71M156.39M135.90M102.40M76.88M58.33M105.69M84.59M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 7.33M7.29M7.55M7.20M6.77M6.39M5.96M5.53M5.11M4.72M
Other Non-Current Assets (Quarter) 4.04M0.29M4.04M4.04M0.11M4.04M4.04M3.23M0.11M3.23M
Non-Current Assets (Quarter) 42.08M41.74M41.58M40.83M39.62M38.86M38.04M36.42M35.62M35.05M
Assets (Quarter) 277.67M247.11M224.29M197.22M175.51M141.26M114.92M94.75M141.31M119.64M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 4.58M5.31M6.17M5.92M7.73M5.83M4.96M2.53M3.98M2.07M
Payables (Quarter) 4.58M5.31M6.17M5.92M7.73M5.83M4.96M2.53M3.98M2.07M
Accumulated Expenses (Quarter) 15.77M10.15M11.43M13.58M15.21M11.30M5.88M6.49M12.53M2.53M
Other Accumulated Expenses (Quarter) 0.94M0.80M0.46M0.80M0.77M0.70M0.86M0.96M0.96M0.91M
Current Leases (Quarter) 1.48M2.19M2.23M2.37M2.49M2.60M2.71M2.73M2.74M2.76M
Current Deferred Revenue (Quarter) 3.00M33.73M30.95M
Total Current Liabilities (Quarter) 21.83M17.64M23.34M22.22M25.64M19.79M20.91M18.19M52.99M41.72M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 1.80M
Operating Leases (Quarter) 15.41M15.45M15.46M18.14M15.32M15.27M15.21M15.13M15.04M14.96M
Other Non-Current Liabilities (Quarter) 3.34M3.28M3.21M3.15M3.09M3.03M2.97M2.90M2.84M2.78M
Total Non-Current Liabilities (Quarter) 37.24M33.09M38.80M37.64M40.97M35.05M36.11M33.32M69.84M56.68M
Total Liabilities (Quarter) 40.58M36.37M42.02M40.79M44.06M38.08M39.08M36.22M72.68M59.46M
Shareholder's Equity
Common Equity (Quarter) 237.09M210.73M182.28M156.43M131.46M103.18M75.84M58.53M68.64M60.18M
Shareholder's Equity (Quarter) 237.09M210.73M182.28M156.43M131.46M103.18M75.84M58.53M68.64M60.18M
Liabilities and Shareholders Equity (Quarter) 277.67M247.11M224.29M197.22M175.51M141.26M114.92M94.75M141.31M119.64M
Retained Earnings (Quarter) -456.39M-487.82M-0.29M-554.80M0.04M-615.60M-646.90M0.00M-683.06M-693.40M
Treasury Shares (Quarter) 0.10M0.09M0.08M0.07M0.06M0.38M0.34M0.29M0.22M0.44M